0.4 |
1.3 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
0.1 |
0.6 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 |
0.2 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 |
0.7 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.1 |
0.3 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) response to glucagon(GO:0033762) |
0.1 |
0.2 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.1 |
0.2 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
0.1 |
0.2 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
0.1 |
1.2 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
0.1 |
0.3 |
GO:0051012 |
microtubule sliding(GO:0051012) |
0.0 |
0.3 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 |
0.3 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 |
0.2 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
0.0 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 |
0.1 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 |
0.7 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
0.0 |
0.3 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
0.0 |
0.1 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
0.0 |
0.3 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 |
0.6 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 |
0.1 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
0.0 |
0.2 |
GO:0032782 |
bile acid secretion(GO:0032782) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 |
0.1 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 |
0.4 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 |
0.1 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
0.0 |
0.8 |
GO:0030901 |
midbrain development(GO:0030901) |
0.0 |
0.0 |
GO:0002586 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.0 |
0.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
0.0 |
0.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 |
0.1 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |